| Metric | FY 2021 | Prior Q | FY 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $462M | — | — | — | — |
| Op. Income | $305M | — | — | — | — |
| Gross Margin | 91.6% | — | — | — | — |
| Net Margin | 49.2% | — | — | — | — |
| EPS (Diluted) | $0.00 | — | — | — | — |
| Free Cash Flow | -$53M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $462M |
| Cost of Revenue | $39M |
| GROSS PROFIT | $423M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $88M |
| SG&A Expenses | $88M |
| Other Expenses | $29M |
| Operating Expenses | $118M |
| Cost & Expenses | $157M |
| OPERATING INCOME | $305M |
| Interest Income | $312M |
| Interest Expense | $34M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $305M |
| Income Tax Expense | $78M |
| Net Income from Continuing Ops | $227M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $227M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $206M |
| D&A | $2M |
| EBIT | $305M |
| EBITDA | $307M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $462M |
| Cost of Revenue | $39M |
| GROSS PROFIT | $423M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $88M |
| SG&A Expenses | $88M |
| Other Expenses | $29M |
| Operating Expenses | $118M |
| Cost & Expenses | $157M |
| OPERATING INCOME | $305M |
| Interest Income | $312M |
| Interest Expense | $34M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $305M |
| Income Tax Expense | $78M |
| Net Income from Continuing Ops | $227M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $227M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $206M |
| D&A | $2M |
| EBIT | $305M |
| EBITDA | $307M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $227M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $5M |
| Other Non-Cash Items | -$51M |
| Change in Working Capital | -$233M |
| OPERATING CASH FLOW | -$49M |
| Capital Expenditure | -$4M |
| Acquisitions (Net) | -$464.0K |
| Purchases of Investments | -$232M |
| Sales/Maturities of Investments | $177M |
| Other Investing Activities | -$414M |
| NET CASH FROM INVESTING | -$474M |
| Net Debt Issuance | -$314M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$31M |
| Other Financing Activities | $1.6B |
| NET CASH FROM FINANCING | $1.4B |
| FREE CASH FLOW | -$53M |
| Net Change in Cash | $853M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.0B |
| Short-Term Investments | $311M |
| Net Receivables | $24M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $1.4B |
| PP&E (Net) | $31M |
| Goodwill | $16M |
| Intangible Assets | $112M |
| Long-Term Investments | $9.6B |
| Tax Assets | $0 |
| Other Non-Current Assets | $128M |
| TOTAL NON-CURRENT ASSETS | $9.9B |
| TOTAL ASSETS | $11.3B |
| Account Payables | $0 |
| Short-Term Debt | $300M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $9.0B |
| TOTAL CURRENT LIABILITIES | $9.3B |
| Long-Term Debt | $874M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $19M |
| Other Non-Current Liabilities | -$53M |
| TOTAL NON-CURRENT LIABILITIES | $841M |
| TOTAL LIABILITIES | $10.1B |
| Common Stock | $138M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $657M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$1M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.2B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.2B |
| TOTAL LIABILITIES & EQUITY | $11.3B |
| Total Debt | $1.2B |
| Net Debt | $141M |
